FULC — Fulcrum Therapeutics Share News
0.000.00%
Last trade - 00:00- $253.21m
- -$80.11m
Fulcrum Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Fulcrum Therapeutics Q2 Basic EPS USD 0.89
Brief: Fulcrum Therapeutics Increased Size Of Board From Eight To Nine Members
U.S. RESEARCH ROUNDUP- Akoya Biosciences, Boston Beer Company, Victory Capital Holdings
U.S. STOCKS ON THE MOVE-Annexon, MKS Instruments, Robinhood
Fulcrum Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-GameStop, AC Immune , Fulcrum Therapeutics
Fulcrum Therapeutics up on licensing deal with Sanofi for muscle disorder drug
Brief: Fulcrum Therapeutics Enters Into A Collaboration And License Agreement With Sanofi
Brief: Fulcrum Therapeutics Q1 Basic EPS USD -0.43
Fulcrum Therapeutics Inc expected to post a loss of 44 cents a share - Earnings Preview
Fulcrum Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Fulcrum Therapeutics Q4 Basic EPS USD -0.4
Fulcrum Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview
Brief: Fulcrum Therapeutics - As Of September 30, 2023, Cash, Cash Equivalents, And Marketable Securities Were $257.1 Million
Brief: Fulcrum Therapeutics Q3 Basic EPS USD -0.39
Fulcrum Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-GMS, Phenomex, Premier
U.S. STOCKS ON THE MOVE-AMTD Digital, BioXcel, Hasbro